Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas

13 Views
administrator
administrator
07/18/23

Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next